GLP-1
Clinical Guide

Patient education

The patient briefings

Three clinical-literacy topics and a structured guide to care access.

01
Access briefing

Best GLP-1 providers: a structured access comparison

Identify the medicine category, the clinical responsibility and the payment model before comparing a service.

02
Briefing 01 / Terminology

Approved, off-label and compounded describe different things

Separate the approval of a product from the use being proposed and the way a preparation is made.

03
Briefing 02 / Medical tests

What is this test meant to answer?

A short framework for understanding a test before it is ordered and its result after it arrives.

04
Briefing 03 / Understanding instructions

Leave the visit with a plan you can explain

Confirm the product, directions, contact route and next review without relying on memory alone.

05
Clinical literacy

Eligibility is more than a website screening result

Product labeling, a clinician’s assessment, program rules and coverage decisions answer different questions.

06
Ongoing care

Follow-up visit: what it means and what to bring to a GLP-1 review

Prepare a record of changes, practical difficulties and questions for the clinician reassessing your plan.

07
Professional roles

The pharmacist has a distinct role in the care plan

Know which questions concern the dispensed product and how to connect them with the prescriber.

08
Scientific article

ESSENCE: Which MASH Patients Were Studied and What the Liver Results Show

The 72-week ESSENCE analysis found improvements in liver inflammation and scarring. Understanding those results requires separating biopsy responses, clinical outcomes, and the evidence behind a treatment plan.

09
Scientific article

ATTAIN-1 oral orforglipron results: weight loss, missing data and discontinuation

The 3,127-participant trial supports oral orforglipron’s weight-management effect, but interpreting it requires separating average losses, responder thresholds, missing data, and today’s Foundayo label.